Drug:
Reaction: BLOOD GLUCOSE INCREASED
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26512236 |
8 | 1 | |
Diarrhoea, Vomiting, Blood glucose decreased, Blood glucose increased, Cough, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 202 | 26512347 |
US |
2 | |
Blood magnesium decreased, Diarrhoea, Fatigue, Blood glucose increased, Nausea, |
||||
CAPIVASERTIB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 203 | 26512408 |
US |
43 | 1 |
Blood glucose increased, Headache, |
||||
PLOZASIRAN, EMPAGLIFLOZIN, FENOFIBRATE, ROSUVASTATIN, ICOSAPENT ETHYL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, MAGNESIUM OXIDE, TIRZEPATIDE, INSULIN LISPRO, FUROSEMIDE, METOLAZONE, UBROGEPANT, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PAMABROM, CAFFEINE, CAFFEINE, MAGNESIUM SALICYLATE, |
||||
| 204 | 26514044 |
JP |
||
Blood glucose increased, Influenza, Abdominal discomfort, Physical deconditioning, Decreased appetite, Nausea, Off label use, |
||||
ZONISAMIDE, ZONISAMIDE, |
||||
| 205 | 26514128 |
US |
68 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 206 | 26514390 |
US |
2 | |
Eye disorder, Asthenia, Dyspnoea, Blood glucose increased, |
||||
RAVULIZUMAB, |
||||
| 207 | 26514948 |
BR |
1043 | 2 |
Acute kidney injury, Blood glucose increased, |
||||
| 208 | 26515209 |
CA |
1 | |
Suicidal ideation, Diarrhoea, Frequent bowel movements, Blood glucose increased, Hypophagia, Anal incontinence, Weight decreased, Feeling of despair, Constipation, Muscular weakness, Fatigue, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, SITAGLIPTIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, BISOPROLOL FUMARATE, ERGOCALCIFEROL, ROSUVASTATIN CALCIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LEVODOPA, |
||||
| 209 | 26515337 |
US |
78 | 2 |
Ketoacidosis, Dehydration, Fall, Ankle fracture, Diabetic retinal oedema, Malabsorption, Weight increased, Decreased appetite, Glycosylated haemoglobin increased, Blood glucose increased, Blood glucose decreased, Injection site haemorrhage, Blood glucose increased, |
||||
INSULIN DEGLUDEC, INSULIN ASPART INJECTION, INSULIN ASPART, SEMAGLUTIDE, ORAL SEMAGLUTIDE, EMPAGLIFLOZIN, |
||||
| 210 | 26515431 |
US |
58 | 1 |
Blood glucose increased, |
||||
| 211 | 26515445 |
US |
2 | |
Blood glucose increased, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, PREDNISONE, |
||||
| 212 | 26515532 |
US |
83 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 213 | 26515771 |
US |
82 | 1 |
Blood glucose increased, |
||||
LECANEMAB, EZETIMIBE, METOPROLOL TARTRATE, METOPROLOL, LOSARTAN, MEMANTINE, MEMANTINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, TIRZEPATIDE, AMLODIPINE, EVOLOCUMAB, LINAGLIPTIN, INSULIN LISPRO, |
||||
| 214 | 26515882 |
CA |
83 | 2 |
Aortic valve thickening, Blood glucose increased, Blood pressure systolic increased, Diarrhoea, Dizziness, Dysuria, Feeling abnormal, Gait inability, Hallucination, Muscle spasms, Urethral pain, Headache, Hypotension, Vomiting, |
||||
MAVACAMTEN, MAVACAMTEN, MAVACAMTEN, MAVACAMTEN, MAVACAMTEN, MAVACAMTEN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, BISOPROLOL FUMARATE, BRIMONIDINE, BRIMONIDINE TARTRATE, CYANOCOBALAMIN, CYCLOPENTOLATE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, BIMATOPROST, DEXAMETHASONE, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, BROMFENAC SODIUM, ROSUVASTATIN, SENNOSIDES, SENNA LEAF, SENNA, STANDARDIZED SENNA CONCENTRATE, ERGOCALCIFEROL, VITAMIN C, ERGOCALCIFEROL, |
||||
| 215 | 26516563 |
CL |
72 | 2 |
Blood glucose increased, Device defective, Drug dose omission by device, |
||||
INSULIN DEGLUDEC, |
||||
| 216 | 26516705 |
EU |
1 | |
Leukopenia, Anaemia, Neutropenia, Muscular weakness, Blood glucose increased, Withdrawal syndrome, Parkinsonism, Insomnia, Blood pressure increased, Drug dependence, |
||||
QUETIAPINE, |
||||
| 217 | 26516724 |
US |
77 | 2 |
Blood glucose increased, Drug ineffective, Injection site indentation, Drug titration error, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, LOSARTAN, |
||||
| 218 | 26507633 |
US |
||
Drug ineffective, Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 219 | 26508099 |
US |
||
Illness, Headache, Blood glucose increased, |
||||
ALBUTEROL SULFATE AND BUDESONIDE, |
||||
| 220 | 26508542 |
US |
1 | |
Blood glucose increased, |
||||
EMPAGLIFLOZIN, |
||||
| 221 | 26509163 |
MX |
62 | 1 |
Blood glucose increased, Dehydration, |
||||
PANITUMUMAB, |
||||
| 222 | 26509171 |
IN |
||
Metabolic acidosis, Rhabdomyolysis, Drug-induced liver injury, Myopathy, Peripheral sensorimotor neuropathy, Urine output decreased, Blood glucose increased, |
||||
| 223 | 26509447 |
US |
79 | 2 |
Blood glucose increased, Incorrect product administration duration, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 224 | 26509448 |
US |
57 | 2 |
Blood glucose increased, Brain fog, Feeling jittery, Malaise, Diarrhoea, Abdominal pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 225 | 26509652 |
IN |
61 | 2 |
Myopathy, Rhabdomyolysis, Drug-induced liver injury, Metabolic acidosis, Peripheral sensorimotor neuropathy, Urine output decreased, Blood glucose increased, |
||||
| 226 | 26509893 |
US |
2 | |
Injection site pain, Blood glucose increased, Incorrect dose administered, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
| 227 | 26510141 |
US |
1 | |
Blood glucose increased, |
||||
BLINATUMOMAB, |
||||
| 228 | 26510155 |
CN |
||
Pyrexia, Pneumonitis, Diarrhoea, Nausea, Vomiting, Blood glucose increased, Blood pressure increased, Off label use, |
||||
RITUXIMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYCLOSPORINE, |
||||
| 229 | 26510516 |
US |
65 | 2 |
Renal failure, Blood pressure increased, Blood glucose increased, |
||||
| 230 | 26510607 |
EU |
78 | 1 |
Pancreatic carcinoma, Blood glucose increased, Hypoglycaemia, |
||||
INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, |
||||
| 231 | 26510869 |
GB |
2 | |
Respiratory failure, Pneumonia, Blood glucose increased, Somnolence, |
||||
CLOZAPINE, CLOZAPINE, |
||||
| 232 | 26511038 |
EU |
2 | |
Iridocyclitis, Blood glucose increased, Hyperkeratosis, Alopecia, Hypoaesthesia, Blood glucose increased, Blood pressure increased, |
||||
DABRAFENIB, DABRAFENIB, TRAMETINIB, TRAMETINIB, |
||||
| 233 | 26511332 |
US |
72 | 1 |
Vision blurred, Incorrect dose administered, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN ASPART, INSULIN DEGLUDEC, |
||||
| 234 | 26511367 |
US |
1 | |
Blood glucose increased, Fluid retention, |
||||
DIAZOXIDE CHOLINE, DIAZOXIDE CHOLINE, CLONIDINE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 235 | 26511571 |
US |
71 | 1 |
Cerebrovascular accident, Extra dose administered, Inappropriate schedule of product administration, Injection site pain, Blood glucose increased, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
| 236 | 26511775 |
CA |
63 | 1 |
Abdominal discomfort, Arthralgia, Asthenia, Blood glucose increased, Contusion, Diverticulitis, Drug ineffective, Eye disorder, Fall, Fatigue, Gait disturbance, Hyperhidrosis, Hypoaesthesia, Impaired driving ability, Insomnia, Loss of personal independence in daily activities, Mobility decreased, Muscle spasms, Pain, Pain in extremity, Peripheral swelling, Rash, Rash pruritic, Rheumatoid arthritis, Skin discolouration, Somnolence, Speech disorder, Walking aid user, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), FOLIC ACID, HYDROXYCHLOROQUINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, NAPROXEN, NAPROXEN SODIUM, HYDROXYCHLOROQUINE SULFATE, |
||||
| 237 | 26511958 |
2 | ||
Brain neoplasm, Blood glucose increased, Acute kidney injury, Somnolence, |
||||
INSULIN GLARGINE, |
||||
| 238 | 26503434 |
EU |
1 | |
Leukopenia, Neutropenia, Drug dependence, Substance-induced psychotic disorder, Anaemia, Muscular weakness, Parkinsonism, Blood glucose increased, Withdrawal syndrome, Blood pressure increased, |
||||
QUETIAPINE, QUETIAPINE, |
||||
| 239 | 26504092 |
CA |
1 | |
Transurethral prostatectomy, Urinary incontinence, Blood glucose increased, Blood pressure increased, |
||||
ABIRATERONE ACETATE, ABIRATERONE, PREDNISONE, |
||||
| 240 | 26504796 |
US |
65 | 1 |
Rhinorrhoea, Blood pressure increased, Blood glucose increased, |
||||
INSULIN HUMAN, |
||||
| 241 | 26504845 |
US |
71 | |
Drug ineffective, Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 242 | 26505268 |
US |
2 | |
Mood altered, Hypoglycaemia, Blood glucose fluctuation, Hepatic function abnormal, Glycosylated haemoglobin increased, Blood glucose increased, Dizziness, Weight increased, Overdose, |
||||
BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, VILAZODONE HYDROCHLORIDE, |
||||
| 243 | 26505475 |
CN |
55 | 2 |
Neutrophil count decreased, White blood cell count decreased, Platelet count decreased, Myelosuppression, Blood glucose increased, Glycosylated haemoglobin increased, Bronchitis, Metastases to bone, Malignant neoplasm progression, |
||||
PALBOCICLIB, INAVOLISIB, INAVOLISIB, INAVOLISIB, FULVESTRANT, |
||||
| 244 | 26505679 |
US |
1 | |
Dementia Alzheimer^s type, Blood glucose increased, Product use issue, |
||||
DAPAGLIFLOZIN, |
||||
| 245 | 26505983 |
US |
68 | 2 |
Blood glucose increased, Diarrhoea, |
||||
| 246 | 26505997 |
US |
66 | 2 |
Blood glucose increased, |
||||
| 247 | 26506396 |
US |
1 | |
Blood bilirubin increased, Jaundice, Hepatic enzyme increased, Blood glucose increased, Cough, Blood urine present, Liver injury, Laboratory test abnormal, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 248 | 26506475 |
78 | 1 | |
Chronic kidney disease, Prostate cancer, Cardiac valve rupture, Blood glucose increased, Hypertension, Blood glucose decreased, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 249 | 26506655 |
US |
1 | |
Blood glucose increased, |
||||
ESKETAMINE HYDROCHLORIDE, |
||||
| 250 | 26506672 |
US |
43 | 2 |
Wrong technique in product usage process, Blood glucose increased, Injection site pain, Injection site erythema, |
||||
INSULIN LISPRO-AABC, |
||||
| 251 | 26506837 |
US |
44 | 2 |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 252 | 26506974 |
US |
2 | |
Blood glucose increased, Lower respiratory tract infection, |
||||
ABATACEPT, TOCILIZUMAB, |
||||
| 253 | 26507051 |
US |
55 | 2 |
Diabetic coma, Vomiting, Diarrhoea, Blood glucose increased, Hypoglycaemia, Hypophagia, Back disorder, Lymphoedema, Insulin resistance, Polycystic ovarian syndrome, Hepatic steatosis, Thyroid disorder, Cardiac disorder, Stress, Illness, Off label use, |
||||
INSULIN LISPRO, INSULIN GLARGINE, INSULIN LISPRO, DULAGLUTIDE, |
||||
| 254 | 26507114 |
US |
2 | |
Constipation, Metabolic disorder, Weight increased, Pain, Food craving, Blood pressure increased, Blood glucose increased, Anal incontinence, General physical health deterioration, Asthenia, Hyperphagia, Feeling abnormal, Dyspepsia, Gastric dilatation, Abdominal distension, Fluid retention, Drug ineffective, Product use issue, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ESCITALOPRAM, |
||||
| 255 | 26507553 |
US |
75 | 1 |
Intervertebral disc protrusion, Blood glucose increased, Peripheral swelling, |
||||
EVOLOCUMAB, EVOLOCUMAB, PREDNISONE, |
||||
| 256 | 26509120 |
74 | 2 | |
Blood glucose increased, Fatigue, Asthenia, Decreased appetite, Headache, Vision blurred, |
||||
INAVOLISIB, |
||||
| 257 | 26509121 |
72 | 2 | |
Blood glucose increased, Hypophagia, |
||||
INAVOLISIB, |
||||
| 258 | 26509621 |
46 | 2 | |
Panic attack, Blood glucose increased, Loss of consciousness, Road traffic accident, Blood sodium decreased, Blood potassium decreased, Skin lesion, Pneumonitis, Noninfective encephalitis, Syncope, Arthropathy, Meniscus injury, Amnesia, Mood swings, Anxiety, Anaemia, Hepatitis, Dyspnoea, Insomnia, Weight decreased, Blindness, Cystitis, Cortisol decreased, Disturbance in attention, Headache, Recurrent cancer, Hepatic cancer, Neoplasm malignant, Lung neoplasm malignant, |
||||
PEMBROLIZUMAB, |
||||
| 259 | 26497924 |
BD |
||
Body tinea, Infection, Injection site infection, Blood glucose increased, Cellulitis, Wrong technique in product usage process, Prescription drug used without a prescription, Intentional product misuse, |
||||
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 260 | 26497942 |
BD |
||
Body tinea, Body tinea, Tinea cruris, Tinea pedis, Infection, Blood glucose increased, Prescription drug used without a prescription, Intentional product misuse, |
||||
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, FLUCONAZOLE, FLUCONAZOLE, FLUCONAZOLE, |
||||
| 261 | 26498147 |
US |
2 | |
Blood pressure increased, Blood glucose increased, Off label use, Anaphylactic reaction, Malaise, |
||||
OMALIZUMAB, OMALIZUMAB, PREDNISONE, DOFETILIDE, |
||||
| 262 | 26498247 |
US |
72 | |
Hypoacusis, Off label use, Blood glucose increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 263 | 26498499 |
IN |
61 | 2 |
Myopathy, Rhabdomyolysis, Drug-induced liver injury, Metabolic acidosis, Peripheral sensorimotor neuropathy, Urine output decreased, Blood glucose increased, |
||||
| 264 | 26498781 |
US |
1 | |
Chest pain, Blood glucose increased, Gastrointestinal motility disorder, Abdominal discomfort, Abdominal pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 265 | 26498785 |
US |
2 | |
Blood glucose increased, Fatigue, Ocular discomfort, |
||||
EMPAGLIFLOZIN AND LINAGLIPTIN, |
||||
| 266 | 26499431 |
US |
2 | |
Blood glucose increased, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 267 | 26499938 |
IN |
61 | 2 |
Myopathy, Rhabdomyolysis, Metabolic acidosis, Peripheral sensorimotor neuropathy, Urine output decreased, Blood glucose increased, Drug-induced liver injury, |
||||
| 268 | 26500308 |
BY |
44 | 2 |
Blood glucose increased, Off label use, |
||||
ALPELISIB, |
||||
| 269 | 26500555 |
US |
64 | 2 |
Incorrect dose administered, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 270 | 26500563 |
BR |
52 | 2 |
Fibromyalgia, Blood glucose increased, Abdominal mass, Dyspnoea, Sleep apnoea syndrome, Product quality issue, Product colour issue, |
||||
SEMAGLUTIDE, |
||||
| 271 | 26500826 |
US |
55 | 1 |
Intercepted product storage error, Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 272 | 26501056 |
75 | 1 | |
Skin necrosis, Liver function test increased, Vomiting, Pancreatitis acute, Blood glucose increased, |
||||
SEMAGLUTIDE, |
||||
| 273 | 26501181 |
US |
67 | 1 |
Pain, Blood sodium decreased, Blood chloride decreased, Rash, Inappropriate schedule of product administration, Neutrophil count increased, Lymphocyte count decreased, Monocyte count decreased, Eosinophil count decreased, Basophil count decreased, Incorrect dose administered, White blood cell count increased, Red blood cell count decreased, Haemoglobin decreased, Haematocrit decreased, Immature granulocyte count increased, Blood glucose increased, |
||||
PEMBROLIZUMAB, GUAIFENESIN, ERGOCALCIFEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 274 | 26501787 |
US |
88 | 2 |
Blood glucose increased, Malaise, Hypoacusis, Eczema, Expired product administered, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 275 | 26501877 |
44 | 2 | |
Somnambulism, Communication disorder, Loss of consciousness, Unresponsive to stimuli, Seizure, Blood glucose increased, |
||||
ZOLPIDEM TARTRATE, |
||||
| 276 | 26502293 |
CO |
33 | 2 |
Diarrhoea, Blood glucose decreased, Asthenia, Tremor, Feeling cold, Weight decreased, Blood glucose increased, Weight increased, Poor quality sleep, Stress, Fear of eating, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 277 | 26502418 |
US |
59 | 1 |
Cholelithiasis, Bile duct stone, Perforation bile duct, Pancreatitis necrotising, Surgery, Stent placement, Blood glucose increased, Blood glucose decreased, Blood glucose increased, |
||||
INSULIN ASPART, |
||||
| 278 | 26497550 |
US |
70 | 2 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN HUMAN, |
||||
| 279 | 26497556 |
US |
55 | |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 280 | 26497646 |
US |
75 | |
Blood glucose increased, Blood glucose decreased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 281 | 26497706 |
US |
12 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 282 | 26497715 |
US |
69 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 283 | 26497739 |
US |
35 | 1 |
Blood glucose increased, Nasopharyngitis, |
||||
INSULIN LISPRO, |
||||
| 284 | 26497754 |
US |
61 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 285 | 26499991 |
64 | 2 | |
Peripheral swelling, Joint swelling, Peripheral swelling, Back pain, Urinary tract infection, Sinusitis, Headache, Myalgia, Bone pain, Ligament pain, Neuralgia, Tendon pain, Hypertension, Blood glucose increased, Respiratory disorder, Musculoskeletal disorder, Hypersensitivity, |
||||
EVOLOCUMAB, FLUOCINONIDE, FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%, FUROSEMIDE, CLONAZEPAM, LISINOPRIL, LORATADINE, LORATADINE ORAL, PREGABALIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 286 | 26496761 |
CN |
2 | |
Renal impairment, Diabetic nephropathy, Blood glucose increased, |
||||
DAPAGLIFLOZIN, |
||||
| 287 | 26496911 |
MX |
73 | 1 |
Pyrexia, Anal incontinence, Discomfort, Oxygen saturation decreased, Infection, Blood glucose increased, Diarrhoea, Asthenia, Tremor, Head titubation, Asthenia, Dysstasia, Gait disturbance, Fatigue, Pain in extremity, |
||||
VENETOCLAX, RITUXIMAB, LOSARTAN, |
||||
| 288 | 26496958 |
US |
88 | 2 |
Product storage error, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 289 | 26497147 |
US |
37 | |
Blood glucose increased, |
||||
TOLVAPTAN, TOLVAPTAN, |
||||
| 290 | 26500491 |
74 | 2 | |
Blood glucose increased, |
||||
PALBOCICLIB, |
||||
| 291 | 26492726 |
US |
2 | |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 292 | 26492853 |
US |
2 | |
Myocardial infarction, Bronchitis, Laryngitis, Hordeolum, Cardiac disorder, Blood glucose increased, Stress, Nasopharyngitis, Cough, Eye swelling, Dyspnoea, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, LAMOTRIGINE, SPIRONOLACTONE, LIDOCAINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, GABAPENTIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CETIRIZINE HYDROCHLORIDE, |
||||
| 293 | 26493277 |
US |
57 | 2 |
Diabetic coma, Near death experience, Lethargy, Blood glucose increased, Asthenia, Fatigue, Dizziness, |
||||
EMPAGLIFLOZIN, |
||||
| 294 | 26493520 |
US |
61 | 1 |
Blood glucose increased, Hernia, |
||||
INSULIN LISPRO, |
||||
| 295 | 26493547 |
BD |
||
Body tinea, Tinea cruris, Infection, Blood glucose increased, Intentional product misuse, Prescription drug used without a prescription, |
||||
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, DEFLAZACORT, TERBINAFINE HYDROCHLORIDE, TERBINAFINE, ITRACONAZOLE, |
||||
| 296 | 26493710 |
US |
73 | 1 |
Blood glucose increased, Device issue, Product dose omission issue, |
||||
INSULIN GLARGINE, |
||||
| 297 | 26494062 |
US |
73 | 2 |
Blood glucose increased, Product use issue, |
||||
RIFAXIMIN, RIFAXIMIN, ENALAPRIL, |
||||
| 298 | 26494075 |
BD |
43 | 1 |
Prescription drug used without a prescription, Blood glucose increased, Body tinea, Body tinea, Tinea cruris, Tinea pedis, Infection, Intentional product misuse, Off label use, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, FLUCONAZOLE, FLUCONAZOLE, FLUCONAZOLE, |
||||
| 299 | 26494624 |
US |
48 | 2 |
Product dose omission issue, Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 300 | 26494688 |
US |
2 | |
Blood glucose increased, Injection site bruising, Injection site discolouration, |
||||
SARILUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SITAGLIPTIN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28